Weekly OHDSI Digest – April 1, 2024


Please join our April 2 (11 am ET) community call for our first “April Olympians” session. Event co-leads Clair Blacketer and Melanie Philofsky will provide the first update, including examples of what the ‘hunters’ and ‘writers’ will do during the month, and details on how to get involved throughout the month. Anton Ivanov will also join to discuss the Perseus ETL tool.

Everybody is invited. Calendar invites went out last week. If you did not receive one, please use this link to join the meeting. All recordings from these weekly calls are available within our Teams environment and will be posted on both our YouTube page and our OHDSI.org Community Calls page.


Upcoming Workgroup Calls – OHDSI


Congratulations to the team of Kipyo Kim, Ji-Eun Kim, Jae Ho Kim, Seong Hee Ahn, Chai Young Jung, Seun Deuk Hwang, Seoung Woo Lee and Joon Ho Song on the publication of Real-world evidence of constipation and laxative use in the Korean population with chronic kidney disease from a common data model in Scientific Reports.

Congratulations to the team of Cindy Cai, Akihiko Nishimura, Mary Bowring, Erik Westlund, Diep Tran, Jia Ng, Paul Nagy, Michael Cook, Jody-Ann McLeggon, Scott DuVall, Michael Matheny, Asieh Golozar, Anna Ostropolets, Evan Minty, Priya Desai, Fan Bu, Brian Toy, Michelle Hribar, Thomas Falconer, Linying Zhang, Laurence Lawrence-Archer, Michael Boland, Kerry Goetz, Nathan Hall, Azza Shoaibi, Jenna Reps, Anthony Sena, Clair Blacketer, Joel Swerdel, Kenar Jhaveri, Edward Lee, Zachary Gilbert, Scott Zeger, Deidra Crews, Marc Suchard, George Hripcsak, and Patrick Ryan on the publication of Similar risk of kidney failure among patients with blinding diseases who receive ranibizumab, aflibercept, and bevacizumab: an OHDSI Network Study in Ophthalmology Retina.

Congratulations to the team of Joshua Ide, Azza Shoaibi, Kerstin Wagner, Rachel Weinstein, Kathleen E. Boyle and Andrew Myers on the publication of Patterns of Comorbidities and Prescribing and Dispensing of Non-steroidal Anti-inflammatory Drugs (NSAIDs) Among Patients with Osteoarthritis in the USA: Real-World Study in Drugs & Aging.

Congratulations to the team of Jens Weidner, Ingmar Glauche, Ulf Manuwald, Ivana Kern, Ines Reinecke, Franziska Bathelt, Makan Amin, Fan Dong, Ulrike Rothe, and Joachim Kugler on the publication of Correlation of Socioeconomic and Environmental Factors With Incidence of Crohn Disease in Children and Adolescents: Systematic Review and Meta-Regression in JMR Public Health and Surveillance.

Congratulations to the team of Valerie van Baalen, Eva-Maria Didden, Daniel Rosenberg, Kristina Bardenheuer, Michel van Speybroeck, and Monika Brand on the publication of Increase transparency and reproducibility of real-world evidence in rare diseases through disease-specific Federated Data Networks in JMR Public Health and Surveillance.


• The third annual OHDSI DevCon will be held virtually on Friday, April 26, from 9 am-3 pm ET.

Join leaders from our Open-Source Community for a day to both welcome and inform both new and veteran developers within the OHDSI Community. More details on the agenda will be posted when available.

• Yong Chen will lead the next edition of the CBER BEST Initiative Seminar Series, which will be held Wednesday, April 17 (11 am – 12 pm ET). Dr. Chen, a 2021 Titan Award honoree, will present his work on “Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents: causal inference under misclassification in treatment status.” This session is open to anybody, and the meeting link is available here.

• The 2024 OHDSI Global Symposium will be held Oct. 22-24 at the Hyatt Regency Hotel in New Brunswick, NJ. The tentative symposium format will feature tutorials on Oct. 22, plenaries and the collaborator showcase on Oct. 23, and workgroup activities on Oct. 24. Registration has not opened yet.

• Registration is now OPEN for the 2024 OHDSI Europe Symposium, which will be held June 1-3 in Rotterdam, Netherlands. There will be tutorials and workshops June 1-2 at the Erasmus University Medical Center, and the main conference will be held Monday, June 3, on the Steam Ship Rotterdam. Please visit the event homepage for more information and registration details.

• Atif Adam announced an opportunity for collaboration around a new network study focusing on Acute ST-Elevation Myocardial Infarction (STEMI). The study intends to deepen the understanding of STEMI patients’ characteristics and identify incidence rates across multiple real-world data datasets. More details and information on how to get involved are available within the forum post.

• Research from the 2023 Global Symposium Collaborator Showcase can be viewed on the Global Symposium Showcase page. Research is also being shared daily on OHDSI’s LinkedInTwitter/X and Instagram feeds as part of the #OHDSISocialShowcase. Below are posters (with study leads) that are featured this week:

Monday — Integrating clinical and laboratory research data using the OMOP CDM (Edward Frankenberger)

Tuesday — A new route of administration hierarchy derived from dose forms supporting standardised drug dose calculations (Theresa Burkard)

Wednesday — Bayesian Evidence Synthesis with Bias Correction (Louisa Smith)

Thursday — Save Our Sisyphus Challenge: Lessons learned from Strategus execution on the OHDSI Network (Anthony Sena)

Friday — Incorporating Real-World Data Research in Training First-Year Medical Students Using OHDSI OMOP and Atlas tools (Pavel Goriacko)

Job Openings

• Alex Asiimwe shared an opening for a Director, RWE – Data Science at Gilead. As a RWE Data Scientist (OMOP/OHDSI), you will play a crucial role in designing, implementing, and maintaining healthcare data solutions using the OHDSI framework. This position offers an exciting opportunity to contribute to advancements in health informatics and research.

• Linying Zhang shared openings for both a Postdoc and a Senior Data Analyst at the Washington University School of Medicine in St. Louis. Successful candidates will work on causal machine learning and responsible AI for reliable real-world evidence generation. Interested applicants should send a CV and cover letter to linyingz@wustl.edu.

• Nathan Hall introduced a summer internship at Johnson & Johnson for an Epidemiology UX/Web Design Intern. This internship provides a unique opportunity to merge design principles with epidemiological research, contributing to the advancement of real-world evidence applications. In this role, you will have the opportunity to blend your passion for user experience (UX) and web design with the field of epidemiology, contributing to impactful projects that enhance our ability to derive insights from health data. More information and an application link are available here.


Accessing MSTeams: To join OHDSI Teams, please fill out this form: Join OHDSI Teams
If you are already in the OHDSI Teams environment and you would like to join work groups in teams, please fill out this form: Join Workgroups, Chapters, and Studies

Duplicate email removal from OHDSI Teams: As you should always be using one email in OHDSI Teams when joining all workgroups, you may remove duplicate emails by filling out this form

To unsubscribe from Teams, please fill out this form

Please continue to collaborate in our MS Teams environment, check out the OHDSI website and forums , and follow us on all platforms, including Twitter and LinkedIn to get continued updates and information on everything happening in our community